Skip to content

    Supreme Petroch.

    SPLPETROGood
    Chemicals·25 Apr 2025
    Management Summary

    Supreme Petrochem delivered a strong sequential recovery in Q4 FY25, despite YoY margin pressure from raw material fluctuations. The company is aggressively pivoting towards higher-margin segments, specifically Mass ABS and specialized compounding through the Xmold acquisition. Management has guided for a 13% volume growth in FY26, underpinned by new capacity commissioning and a robust debt-free balance sheet.

    Highlights

    8
    • Operating income for Q4 FY25 stood at ₹1,539 crores, up 99.5% QoQ but down 1.5% YoY.

    • Full-year FY25 operating income reached ₹6,023 crores, marking a 14.6% YoY increase.

    • Q4 EBITDA was ₹163 crores, a 40% sequential increase, though down 15.9% on a YoY basis.

    • Net profit for the full year FY25 was ₹390 crores, with Q4 contributing ₹107 crores.

    • Manufactured product sales volume grew by 9.4% YoY for the full year, driven by strong demand.

    • The company remains debt-free with an investable surplus of ₹872 crores as of March 2025.

    • Phase 1 of the Mass ABS project is expected to be mechanically complete by May 2025.

    • Acquired Xmold Polymers, adding 15,000 tonnes of compounding capacity with a revenue potential of ₹200 crores.

    Key financials

    Single quarter

    05 metrics
    1. 01Operating Income₹1,539 Cr-1.5%YoY
    2. 02EBITDA₹163 Cr-15.9%YoY
    3. 03PAT₹107 Cr
    4. 04Manufactured Volume Growth9.4%+9.4%YoY
    5. 05Capacity Utilization79%

    Segment breakdown

    Manufactured Products
    66.6% Polystyrene Share25% EPS Share10% Compounds and XPS Share
    Trading Business
    23% Revenue Share
    List

    Guidance & targets

    5
    CategoryTargetPriority
    Volume
    Overall Volume Growth
    13%
    High
    Capex
    FY26 Cash Capex
    ₹200 crores
    High
    Capacity
    Compounding Capacity
    70,000 tonnes
    High
    Revenue
    Compounding Peak Revenue Potential
    ₹1,000 crores
    Medium
    Margin
    3D Board EBITDA Margin
    35%
    Medium

    Risks & concerns

    5
    RiskSeverity

    Raw Material Price Volatility

    Styrene monomer prices fluctuated +/-10% during the year and have shown a downward trend since March 2025.Management acknowledged

    medium

    China Dumping/Tariff Impacts

    Management believes China consumes most Styrene in-house and doesn't expect US-China trade flows to significantly alter Indian market dynamics.Analyst downplayed

    low

    Increased Competition in North India

    Competitors like Styric and EPACK have expanded capacity in EPS, which may limit volume growth in the domestic North Indian market.Both acknowledged

    medium

    Areas of Evasion(2)

    • Specific export vs domestic revenue bifurcation
    • Detailed EBITDA margins for the ABS segment at this early stage

    Q&A highlights

    3

    “Earlier utilization was only around 60%... Xmold had a revenue of Rs.72 crores. So, going by that, the total potential is closer to Rs.200 crores for this business.”

    Reveals the immediate revenue upside from the acquisition and the entry into the automotive sector.

    asked by Sailesh Raja

    2 min read5 chapters

    Detailed Narrative

    01

    Strategic Pivot to Mass ABS and Compounding

    Supreme Petrochem is undergoing a significant structural shift by entering the Mass ABS market. Phase 1 of the project, with a capacity of 70,000 tonnes, is nearing mechanical completion in May 2025, with revenue contribution expected to ramp up from Q2 FY26. The company has invested approximately ₹600 crores in this phase, which includes shared infrastructure for a planned second line of another 70,000 tonnes. This second line is estimated to cost significantly less (₹250-300 crores) and is targeted for commissioning within the next two years.

    02

    Xmold Acquisition and Automotive Entry

    The acquisition of Xmold Polymers marks the company's formal entry into the automotive compounding sector, a segment where they previously had minimal presence. Xmold currently operates at 40-60% utilization with ₹72 crores in revenue, but management sees a clear path to ₹200 crores at full capacity. Post-expansion, the total compounding capacity will reach 70,000 tonnes with a peak revenue potential of ₹1,000 crores, diversifying the company's reliance away from the appliances sector.

    03

    Volume Growth and Market Dynamics

    Management has set a firm volume growth target of 13% for FY26. This growth is expected to be split, with roughly 50-60% coming from the new ABS/ABS compounds capacity and the remainder from the base business. While the domestic EPS market faces increased competition from new players in North India, the company is pivoting towards exports, having secured grade approvals in the GCC and Europe to offset local volume pressure.

    04

    Financial Resilience and Capex Efficiency

    The company maintains an exceptionally strong balance sheet with zero debt and ₹872 crores in investable surplus. FY26 cash capex is guided at a relatively modest ₹200 crores, as much of the heavy lifting for ABS Phase 1 has already been expensed. The company's ability to fund massive expansions internally while maintaining a high dividend payout (₹10 per share for FY25) highlights its strong cash generation capabilities.

    05

    Cost Management and Operational Efficiency

    Operational efficiency is being bolstered by a shift to solar power, which began in October 2024 and is expected to reduce power costs by 2-3% in FY26 despite rising capacity utilization. Logistics costs, which rose to ₹125 crores in FY25, are being monitored closely, though management noted that freight prices have largely normalized to pre-COVID levels. Inventory management remains a focus following a ₹220 crore spike in Q4, which management attributed to timing of arrivals rather than demand softness.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.